Expansion of Haematopoietic Stem and Progenitor Cells: Paving the Way for Next-Generation Haematopoietic Stem Cell Transplantation

Overview

Journal Blood Cell Ther

Date 2023 Aug 17

PMID 37588101

Authors

Sudipto Bari

Paul Chong

William Ying Khee Hwang

Affiliations

Soon will be listed here.

Abstract

Haematopoietic stem cell transplantation (HSCT) is now an established practice with over 70,000 transplants performed annually, and over 1.5 million around the world so far. The practice of HSCT has improved over the years due to advances in conditioning regiments, preparatory practices for patients leading up to the transplant, graft versus host disease (GVHD) and infection prophylaxis, as well as a better selection of patients. However, in many instances, the stem cells supplied to the patient may not be adequate for optimal transplantation outcomes. This may be seen in a few areas including umbilical cord blood transplantation, inadequate bone marrow, peripheral blood stem cell harvest, or gene therapy. Growing and expanding HSCs in culture would provide an increase in cell numbers prior to stem cell infusion and accelerate haematopoietic recovery, resulting in improved outcomes. Several new technologies have emerged in recent years, which have facilitated the expansion of haematopoietic stem and progenitor cells (HSPCs) in culture with good outcomes , , and in clinical trials. In this review, we will outline some of the reasons for the expansion of HSPCs as well as the new technologies facilitating the advances in HSCT.

References

Heinz N, Ehrnstrom B, Schambach A, Schwarzer A, Modlich U, Schiedlmeier B . Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells. Stem Cells Transl Med. 2015; 4(9):1064-72. PMC: 4542867. DOI: 10.5966/sctm.2014-0284. View

Peled T, Shoham H, Aschengrau D, Yackoubov D, Frei G, Rosenheimer G N . Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. Exp Hematol. 2011; 40(4):342-55.e1. DOI: 10.1016/j.exphem.2011.12.005. View

Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Lechowicz M . Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion. 2011; 51(10):2175-82. DOI: 10.1111/j.1537-2995.2011.03136.x. View

Stiff P, Montesinos P, Peled T, Landau E, Goudsmid N, Mandel J . Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. Biol Blood Marrow Transplant. 2018; 24(7):1463-1470. PMC: 6045964. DOI: 10.1016/j.bbmt.2018.02.012. View

Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin P, Driscoll T . Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003; 101(12):5061-7. DOI: 10.1182/blood-2001-12-0290. View

Rocha V, Wagner Jr J, Sobocinski K, Klein J, Zhang M, Horowitz M . Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000; 342(25):1846-54. DOI: 10.1056/NEJM200006223422501. View

Leen A, Bollard C, Mendizabal A, Shpall E, Szabolcs P, Antin J . Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 2013; 121(26):5113-23. PMC: 3695359. DOI: 10.1182/blood-2013-02-486324. View

Little M, Storb R . History of haematopoietic stem-cell transplantation. Nat Rev Cancer. 2002; 2(3):231-8. DOI: 10.1038/nrc748. View

Ruella M, Xu J, Barrett D, Fraietta J, Reich T, Ambrose D . Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell. Nat Med. 2018; 24(10):1499-1503. PMC: 6511988. DOI: 10.1038/s41591-018-0201-9. View

10.

Bari S, Seah K, Poon Z, Sze Cheung A, Fan X, Ong S . Expansion and homing of umbilical cord blood hematopoietic stem and progenitor cells for clinical transplantation. Biol Blood Marrow Transplant. 2015; 21(6):1008-19. DOI: 10.1016/j.bbmt.2014.12.022. View

11.

Sun H, Tsai Y, Nowak I, Liesveld J, Chen Y . Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis. Stem Cell Res. 2012; 9(2):77-86. PMC: 3412938. DOI: 10.1016/j.scr.2012.05.001. View

12.

Gyurkocza B, Sandmaier B . Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood. 2014; 124(3):344-53. PMC: 4102707. DOI: 10.1182/blood-2014-02-514778. View

13.

Maher D, Lieschke G, Green M, Bishop J, Stuart-Harris R, Wolf M . Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med. 1994; 121(7):492-501. DOI: 10.7326/0003-4819-121-7-199410010-00004. View

14.

Mahmud N, Petro B, Baluchamy S, Li X, Taioli S, Lavelle D . Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells. Biol Blood Marrow Transplant. 2013; 20(4):480-9. PMC: 8756349. DOI: 10.1016/j.bbmt.2013.12.562. View

15.

BitMansour A, Cao T, Chao S, Shashidhar S, Brown J . Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. Blood. 2004; 105(9):3535-7. PMC: 1895020. DOI: 10.1182/blood-2004-07-2676. View

16.

Kiernan J, Damien P, Monaghan M, Shorr R, McIntyre L, Fergusson D . Clinical Studies of Ex Vivo Expansion to Accelerate Engraftment After Umbilical Cord Blood Transplantation: A Systematic Review. Transfus Med Rev. 2017; 31(3):173-182. DOI: 10.1016/j.tmrv.2016.12.004. View

17.

Maude S, Frey N, Shaw P, Aplenc R, Barrett D, Bunin N . Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014; 371(16):1507-17. PMC: 4267531. DOI: 10.1056/NEJMoa1407222. View

18.

Zhang C, Kaba M, Ge G, Xie K, Tong W, Hug C . Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med. 2006; 12(2):240-5. PMC: 2771412. DOI: 10.1038/nm1342. View

19.

Rubin R . Gene Therapy for Sickle Cell Disease Shows Promise. JAMA. 2019; 321(4):334. DOI: 10.1001/jama.2018.21119. View

20.

Karanu F, Murdoch B, Gallacher L, Wu D, Koremoto M, Sakano S . The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med. 2000; 192(9):1365-72. PMC: 2193352. DOI: 10.1084/jem.192.9.1365. View